Market Research Report
Oxygen Therapy Devices Market (Product Type (Oxygen Source Equipment & Oxygen Delivery Devices) and Applications) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
|Published by||Transparency Market Research||Product code||326018|
|Published||Content info||98 Pages
Delivery time: 1-2 business days
|Oxygen Therapy Devices Market (Product Type (Oxygen Source Equipment & Oxygen Delivery Devices) and Applications) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020|
|Published: January 27, 2015||Content info: 98 Pages||
This report on oxygen therapy devices market studies the current as well as future prospects of the market globally. Oxygen therapy devices are rapidly gaining popularity in the global market due to their wide range of applications in the treatment and management of COPD, asthma, obstructive sleep apnea, pneumonia, and cystic fibrosis. The largest application for oxygen therapy devices is COPD, as the prevalence of fatal respiratory diseases is rapidly gaining momentum. This report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments and sub-segments of the oxygen therapy devices market. It also provides information and data analysis of the global oxygen therapy market with respect to market segments based on the type of products, applications and geographic markets.
Based on product types, the oxygen therapy devices market is segmented into two major segments: oxygen source equipment and oxygen delivery devices. The oxygen source equipment is further categorized into oxygen cylinders, oxygen concentrators and liquid oxygen devices. Similarly, the oxygen delivery devices market is sub-segmented into simple oxygen masks, nasal cannula, venturi masks, non-rebreather masks, bag valve masks and CPAP masks. The oxygen therapy devices market has also been segmented based on application areas that include chronic obstructive pulmonary disease (COPD), asthma, obstructive sleep apnea, respiratory distress syndrome, cystic fibrosis and pneumonia. The market segments have been extensively analyzed based on their usefulness, efficacy, revenue and geographic coverage. The market size and forecast in terms of USD million for each market segment has been provided for the period from 2012 to 2020. The report also provides the compounded annual growth rate (CAGR%) for each market segment for the forecast period from 2014 to 2020, considering 2013 as the base year.
Geographically, the global oxygen therapy devices market is categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). The market size and forecast for each of these regions is provided for the period from 2012 to 2020, along with their respective CAGRs for the forecast period from 2014 to 2020, considering 2013 as the base year. The research study also incorporates the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the market and future opportunities have been provided in the market overview section. This section also provides market attractiveness analysis, Porter's five forces analysis and market share analysis of the the key players in 2013 in order to present a thorough analysis of the overall competitive scenario in the global oxygen therapy devices market.
A list of recommendations is provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market and thereby establish their foothold. The report also profiles major players of the oxygen therapy devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies and recent developments. Major players profiled in this report include CareFusion Corporation, DeVilbiss Healthcare, LLC, Fisher & Paykel Healthcare Limited, MAQUET Holding B.V. & Co. KG, Smiths Medical, Teleflex Incorporated, Invacare Corporation, Philips Respironics, Inc., and AirSep Corporation.